Predictive Value of Post-Transplant Bone Marrow Plasma Cell Percent in Multiple Myeloma Patients Undergone Autologous Transplantation |
Hwang, In-Hye
(Department of Internal Medicine, School of Medicine, Pusan National University)
Chung, Joo-Seop (Department of Internal Medicine, School of Medicine, Pusan National University) Shin, Ho-Jin (Department of Internal Medicine, School of Medicine, Pusan National University) Choi, Young-Jin (Department of Internal Medicine, School of Medicine, Pusan National University) Song, Moo-Kon (Department of Internal Medicine, School of Medicine, Pusan National University) Seol, Young-Mi (Department of Internal Medicine, School of Medicine, Pusan National University) Cho, Goon-Jae (Department of Internal Medicine, School of Medicine, Pusan National University) Choi, Bo-Gwang (Department of Internal Medicine, School of Medicine, Pusan National University) Choi, Mun-Ki (Department of Internal Medicine, School of Medicine, Pusan National University) Choi, Bo-Kyung (Department of Internal Medicine, School of Medicine, Pusan National University) Ahn, Kang-Hee (Department of Internal Medicine, School of Medicine, Pusan National University) Shin, Kyung-Hwa (Department of Internal Medicine, School of Medicine, Pusan National University) Lee, Hee-Sun (Department of Internal Medicine, School of Medicine, Pusan National University) Nam, Hyung-Seok (Department of Internal Medicine, School of Medicine, Pusan National University) Hwang, Jong-Min (Department of Internal Medicine, School of Medicine, Pusan National University) |
1 | Attal M, Harousseau JL, Stoppa AM, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myéloma. Intergroupe Francais du Myelome. N Engl J Med 1996;335:91-97. DOI ScienceOn |
2 | Child JA, Morgan GJ, Davies FE, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003;348:1875-1883. DOI ScienceOn |
3 | Bjorkstrand B, Svensson H, Goldschmidt H, et al. Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2001;27:511-515. DOI ScienceOn |
4 | Stewart AK, Bergsagel PL, Greipp PR, et al. A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy. Leukemia 2007;21:529-534. DOI ScienceOn |
5 | Avet-Loiseau H, Attal M, Moreau P, et al. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome. Blood 2007;109:3489-3495. DOI ScienceOn |
6 | Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol 2005;23:3412-3420. DOI ScienceOn |
7 | Barlogie B, Shaughnessy J, Tricot G, et al. Treatment of multiple myeloma. Blood 2004;103:20-32. DOI ScienceOn |
8 | Fonseca R, Blood E, Rue M, et al. Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 2003;101:4569-4575. DOI ScienceOn |
9 | Rajkumar S, Fonseca R, Lacy M, et al. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma. Bone Marrow Transplant 1999;24:497-503. DOI ScienceOn |
10 | Worel N, Greinix H, Ackermann J, et al. Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma. Ann Hematol 2001;80:345-348. DOI ScienceOn |
11 | Alexanian R, Weber D, Giralt S, et al. Impact of complete remission with intensive therapy in patients with responsive multiple myeloma. Bone Marrow Transplant 2001;27:1037-1043. DOI ScienceOn |
12 | Dingli D, Pacheco JM, Nowakowski GS, et al. Relationship between depth of response and outcome in multiple myeloma. J Clin Oncol 2007;25:4933-4937. DOI ScienceOn |
13 | Kim JS, Kim K, Cheong JW, et al. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. Biol Blood Marrow Transplant 2009;15:463-470. DOI ScienceOn |
14 | Lahuerta JJ, Mateos MV, Martínez-López J, et al. Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival. J Clin Oncol 2008;26:5775-5782. DOI ScienceOn |
15 | Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia 2006;20:1467-1473. DOI ScienceOn |
16 | Chee CE, Kumar S, Larson DR, et al. The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma. Blood 2009;114:2617-2618. DOI ScienceOn |